Kurs & Likviditet
|2022-10-25||Ordinarie utdelning HEALTH 0.00 EUR|
|2021-10-29||Ordinarie utdelning HEALTH 0.00 EUR|
|Lista||First North Finland|
Company release, 27 October 2022 at 11.25 p.m. (EEST)
Nightingale Health Plc's Annual Report for financial year 1 July 2021-30 June 2022 has been published. The publication includes the Board of Directors' Report, the Consolidated and Parent Company Financial Statements, the Corporate Governance Statement, and the Remuneration Report.
The Annual Report, Board of Directors' Report, the Consolidated and Parent Company Financial Statements, the Corporate Governance Statement, and the Remuneration Report are attached to this release and are also available on Nightingale Health's website at www.nightingalehealth.com/investors/.
Nightingale Health will publish the Auditor's Report to the Financial Statements at a later announced date approximately within a week. The Auditor's Report is expected to be unqualified. The Auditor's Report is released after the release of the Financial Statements due to the transition to report in accordance with the International Financial Reporting Standards ("IFRS") instead of the Finnish Accounting Standards ("FAS") as of the financial year ended on 30 June 2022, which has caused a delay in the release schedule of the Auditor's Report.
For further information, please contact:
Teemu Suna, CEO
Oaklins Merasco Ltd, tel. +358 9 6129 670
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it's also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.
Annual Report 2021-2022
Board of Directors' Report and Consolidated and Parent Company Financial Statements 2021-2022
Corporate Governance Statement 2021-2022
Remuneration Report 2021-2022